New shot targets cellulite: small study tests qwo on butt and thighs

NCT ID NCT05026216

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed Phase 4 study tested multiple doses of Qwo, a drug made from bacterial enzymes, for treating mild to moderate cellulite in adult women. Five participants received injections in their buttocks and thighs over three sessions. The goal was to see if the treatment improved the look of cellulite as judged by a doctor.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Qwo (collagenase clostridium histolyticum-aaes)

What this could lead to

If it works, this could offer a non-surgical option to reduce the appearance of cellulite on buttocks and thighs.

What could go wrong

This is a very small, early-phase study with only 5 participants, so results may not apply to everyone. Cellulite treatments often show modest improvements.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CELLULITE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cellulite cellulitis lipodermatosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • DMR Research, PLLC

    Westport, Connecticut, 06880, United States